| __timestamp | Geron Corporation | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 4101058 |
| Thursday, January 1, 2015 | 17831000 | 10763215 |
| Friday, January 1, 2016 | 18047000 | 5579049 |
| Sunday, January 1, 2017 | 11033000 | 32051299 |
| Monday, January 1, 2018 | 13432000 | 24482286 |
| Tuesday, January 1, 2019 | 52072000 | 43892589 |
| Wednesday, January 1, 2020 | 51488000 | 44505000 |
| Friday, January 1, 2021 | 85727000 | 79406000 |
| Saturday, January 1, 2022 | 95518000 | 49283000 |
| Sunday, January 1, 2023 | 125046000 | 17282730 |
Data in motion
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Geron Corporation and Verona Pharma plc have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Geron Corporation's R&D expenses surged by nearly 500%, peaking in 2023. This consistent increase underscores Geron's strategic focus on advancing its pipeline, particularly in the field of telomerase inhibition.
Verona Pharma's R&D spending, on the other hand, has been more volatile. After a significant rise in 2017, expenses fluctuated, reflecting the company's adaptive strategy in respiratory therapeutics. Notably, 2021 marked a high point, with spending nearly doubling from 2014 levels.
These trends highlight the diverse strategies employed by biotech firms in their quest for innovation.
Research and Development Investment: Zoetis Inc. vs Verona Pharma plc
Research and Development: Comparing Key Metrics for Genmab A/S and Geron Corporation
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Research and Development Investment: Sarepta Therapeutics, Inc. vs Verona Pharma plc
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Analyzing R&D Budgets: Verona Pharma plc vs CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Verona Pharma plc and Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Verona Pharma plc and HUTCHMED (China) Limited
R&D Spending Showdown: Verona Pharma plc vs Dynavax Technologies Corporation
Research and Development: Comparing Key Metrics for Verona Pharma plc and Celldex Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Geron Corporation